Compare ORC & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORC | PAHC |
|---|---|---|
| Founded | 2010 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2011 | 2014 |
| Metric | ORC | PAHC |
|---|---|---|
| Price | $6.51 | $39.94 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 4 |
| Target Price | $7.50 | ★ $41.25 |
| AVG Volume (30 Days) | ★ 3.9M | 200.8K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 17.07% | 0.91% |
| EPS Growth | N/A | ★ 104.20 |
| EPS | N/A | ★ 2.43 |
| Revenue | N/A | ★ $833,350,000.00 |
| Revenue This Year | $21.28 | $17.03 |
| Revenue Next Year | $5.71 | $3.82 |
| P/E Ratio | ★ N/A | $16.43 |
| Revenue Growth | N/A | ★ 4.12 |
| 52 Week Low | $6.31 | $28.25 |
| 52 Week High | $8.40 | $60.08 |
| Indicator | ORC | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 40.91 | 74.99 |
| Support Level | $6.42 | $38.26 |
| Resistance Level | $7.00 | $42.82 |
| Average True Range (ATR) | 0.09 | 1.51 |
| MACD | -0.01 | 0.42 |
| Stochastic Oscillator | 3.23 | 90.56 |
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.